Full Breakdown
Alarming Surge in Kratom-Related Health Issues
3/29/2026, 2:46:14 AM
Significant Rise in Kratom Exposure Reports
Between 2015 and 2025, calls to U.S. poison centers regarding kratom surged by over 1,200%, culminating in a record 3,434 exposure reports in 2025, according to an analysis published in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR). This increase corresponds with a notable rise in hospitalizations and severe health outcomes, including 233 deaths linked to kratom during the same period. The majority of these fatalities involved multiple substances, with opioids implicated in 62% of cases.
Demographic Trends and Health Risks
The data indicates that most exposure reports involved males and adults aged 20-39, with a significant increase among individuals aged 40-59 by 2025. The rise in hospitalizations tied solely to kratom escalated from 43 in 2015 to 538 in 2025, marking an increase of over 1,150%. Notably, 60% of multi-substance exposure reports in 2025 resulted in serious medical outcomes, with half requiring hospitalization. The combination of kratom with substances such as alcohol, opioids, and benzodiazepines has been associated with the most severe health consequences.
Nature and Legal Status of Kratom
Kratom, derived from the leaves of the Mitragyna speciosa tree native to Southeast Asia, has been traditionally used for pain relief and to alleviate opioid withdrawal symptoms. In the U.S., it is available in various forms, including powders, capsules, and concentrated extracts. The FDA has stated that kratom is not legally marketed as a drug or dietary supplement, and it has taken steps to restrict products containing the potent alkaloid 7-hydroxymitragynine (7-OH), which exhibits strong opioid-like effects.
Official Statements and Responses
Dr. Chris Holstege, director of the Blue Ridge Poison Center at the University of Virginia, remarked, “The data reflects a concerning trend... with more patients presenting to UVA Health following serious complications associated with kratom products.” Richard Fogelson, CEO of America’s Poison Centers, emphasized the role of poison centers in providing critical medical advice for potential poison exposures.
Criticism and Calls for Regulation
Health and Human Services Secretary Robert F. Kennedy Jr. has advocated for a federal crackdown on 7-OH products, proposing that they be classified as Schedule I substances due to their high potential for abuse. The American Kratom Association, traditionally a supporter of kratom, has also called for regulation of chemically altered 7-OH products, stating, “These 7-OH products are not kratom... and pose an imminent threat to consumers.”
Conflicting Reports and Gaps
While the CDC and various health experts report a significant increase in kratom-related health issues, some advocates argue that kratom can be used safely when consumed responsibly. The debate continues regarding the need for regulation versus the potential benefits of kratom for certain individuals.
What's Next
The CDC authors have urged ongoing surveillance to identify high-risk patterns, particularly concerning multi-substance use, and to inform public education and clinical care. As the situation evolves, further regulatory actions may be anticipated to address the health risks associated with kratom and its derivatives.
